Symbols / PRVA Stock $24.51 +3.24% Privia Health Group, Inc.

Healthcare • Health Information Services • United States • NMS
PRVA (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Parth Mehrotra
Exch · Country NMS · United States
Market Cap 3.09B
Enterprise Value 2.73B
Income 21.76M
Sales 2.25B
FCF (ttm) 110.66M
Book/sh 5.99
Cash/sh 3.33
Employees 1,226
Insider 10d —
IPO Apr 28, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 144.18
Forward P/E 22.34
PEG —
P/S 1.37
P/B 4.09
P/C —
EV/EBITDA 57.22
EV/Sales 1.22
Quick Ratio 1.55
Current Ratio 1.61
Debt/Eq 1.12
LT Debt/Eq —
EPS (ttm) 0.17
EPS next Y 1.10
EPS Growth -33.30%
Revenue Growth 25.80%
EPS Gr Q/Q -27.40%
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-07
ROA 1.75%
ROE 3.62%
ROIC —
Gross Margin 9.97%
Oper. Margin 1.23%
Profit Margin 0.97%
Shs Outstand 126.01M
Shs Float 113.18M
Insider Own 6.30%
Instit Own 97.45%
Short Float 3.94%
Short Ratio 3.06
Short Interest 3.33M
52W High 26.51
vs 52W High -7.54%
52W Low 18.77
vs 52W Low 30.58%
Beta 0.87
Impl. Vol. 7.81%
Rel Volume 0.86
Avg Volume 964.17K
Volume 830.59K
Target (mean) $31.42
Tgt Median $31.00
Tgt Low $24.00
Tgt High $40.00
# Analysts 19
Recom Strong_buy
Prev Close $23.74
Price $24.51
Change 3.24%
About

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$31.42
Mean price target
2. Current target
$24.51
Latest analyst target
3. DCF / Fair value
$15.81
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$24.51
Low
$24.00
High
$40.00
Mean
$31.42

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-26 main Barclays Equal-Weight → Equal-Weight $24
2026-05-08 main Canaccord Genuity Buy → Buy $34
2026-04-08 main Evercore ISI Group Outperform → Outperform $26
2026-03-25 main Barclays Equal-Weight → Equal-Weight $25
2026-03-03 main Citigroup Buy → Buy $32
2026-03-02 main Truist Securities Buy → Buy $33
2026-02-27 main Canaccord Genuity Buy → Buy $35
2025-12-04 reit Stephens & Co. Overweight → Overweight $32
2025-11-13 main JP Morgan Overweight → Overweight $33
2025-11-13 init BMO Capital — → Outperform $30
2025-11-12 main Canaccord Genuity Buy → Buy $34
2025-11-10 main Barclays Equal-Weight → Equal-Weight $23
2025-11-10 reit Truist Securities Buy → Buy $31
2025-11-07 main Evercore ISI Group Outperform → Outperform $30
2025-11-07 main Citizens Market Outperform → Market Outperform $31
2025-10-09 main Barclays Equal-Weight → Equal-Weight $22
2025-09-24 reit Stephens & Co. Overweight → Overweight $32
2025-09-04 reit Stephens & Co. Overweight → Overweight $32
2025-08-29 main JMP Securities Market Outperform → Market Outperform $30
2025-08-11 main Piper Sandler Overweight → Overweight $35
News
RSS: Latest PRVA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-20 RYU JAEWON Director — 8,463 $0.00 $0
2026-05-20 SOISTMAN FRANCIS S JR Director — 8,463 $0.00 $0
2026-05-20 BERBERIAN LANCE V Director — 8,463 $0.00 $0
2026-05-20 KIMMET PAMELA O'BRIEN Director — 8,463 $0.00 $0
2026-05-20 COCOZZA NANCY G Director — 8,463 $0.00 $0
2026-05-20 KING DAVID P Director — 8,463 $0.00 $0
2026-05-20 MORRIS MATTHEW SHAWN Director — 8,463 $0.00 $0
2026-05-20 MCCARTHY THOMAS A Director — 8,463 $0.00 $0
2026-05-12 MEHROTRA PARTH Chief Executive Officer — 121,086 $22.55 $2,731,898
2026-05-11 MOUNTCASTLE DAVID Chief Financial Officer — 3,385 $22.60 $76,501
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
2,122.84
+22.26%
1,736.39
+4.74%
1,657.74
+22.19%
1,356.66
Operating Revenue
2,113.66
+22.33%
1,727.84
+4.77%
1,649.23
+22.10%
1,350.71
Cost Of Revenue
1,913.41
+22.69%
1,559.54
+4.23%
1,496.24
+22.45%
1,221.88
Reconciled Cost Of Revenue
1,913.41
+22.69%
1,559.54
+4.23%
1,496.24
+22.45%
1,221.88
Gross Profit
209.43
+18.42%
176.85
+9.51%
161.50
+19.82%
134.78
Operating Expense
175.19
+9.59%
159.87
+13.50%
140.85
-8.48%
153.90
Selling General And Administration
165.29
+8.31%
152.60
+13.61%
134.32
-10.05%
149.33
Selling And Marketing Expense
27.14
+2.61%
26.45
+6.93%
24.73
+25.28%
19.74
General And Administrative Expense
138.15
+9.51%
126.16
+15.12%
109.59
-15.44%
129.59
Other Gand A
138.15
+9.51%
126.16
+15.12%
109.59
-15.44%
129.59
Total Expenses
2,088.61
+21.47%
1,719.41
+5.03%
1,637.09
+18.99%
1,375.78
Operating Income
34.23
+101.60%
16.98
-17.76%
20.65
+207.99%
-19.12
Total Operating Income As Reported
34.23
+101.60%
16.98
-17.76%
20.65
+207.99%
-19.12
EBITDA
44.14
+82.03%
24.25
-10.79%
27.18
+286.81%
-14.55
Normalized EBITDA
44.14
+82.03%
24.25
-10.79%
27.18
+286.81%
-14.55
Reconciled Depreciation
9.91
+36.31%
7.27
+11.25%
6.53
+42.92%
4.57
EBIT
34.23
+101.60%
16.98
-17.76%
20.65
+207.99%
-19.12
Net Income
22.92
+59.33%
14.38
-37.67%
23.08
+368.83%
-8.59
Pretax Income
43.94
+57.65%
27.87
-3.97%
29.02
+256.19%
-18.58
Net Non Operating Interest Income Expense
9.70
-10.88%
10.89
+30.05%
8.37
+1444.65%
0.54
Interest Expense Non Operating
—
—
—
—
Net Interest Income
9.70
-10.88%
10.89
+30.05%
8.37
+1444.65%
0.54
Interest Expense
—
—
—
—
Tax Provision
14.21
+31.28%
10.83
+35.44%
7.99
+222.67%
-6.52
Tax Rate For Calcs
0.00
-16.73%
0.00
+41.25%
0.00
-21.65%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
29.73
+74.41%
17.04
-18.95%
21.03
+274.30%
-12.06
Net Income From Continuing Operation Net Minority Interest
22.92
+59.33%
14.38
-37.67%
23.08
+368.83%
-8.59
Net Income From Continuing And Discontinued Operation
22.92
+59.33%
14.38
-37.67%
23.08
+368.83%
-8.59
Net Income Continuous Operations
29.73
+74.41%
17.04
-18.95%
21.03
+274.30%
-12.06
Minority Interests
-6.81
-156.00%
-2.66
-229.64%
2.05
-41.05%
3.48
Normalized Income
22.92
+59.33%
14.38
-37.67%
23.08
+368.83%
-8.59
Net Income Common Stockholders
22.92
+59.33%
14.38
-37.67%
23.08
+368.83%
-8.59
Diluted EPS
0.19
+72.73%
0.11
-42.11%
0.19
+337.50%
-0.08
Basic EPS
0.19
+58.33%
0.12
-40.00%
0.20
+350.00%
-0.08
Basic Average Shares
122.18
+2.32%
119.40
+2.29%
116.73
+5.45%
110.70
Diluted Average Shares
128.89
+2.61%
125.61
+0.74%
124.69
+12.64%
110.70
Diluted NI Availto Com Stockholders
22.92
+59.33%
14.38
-37.67%
23.08
+368.83%
-8.59
Depreciation Amortization Depletion Income Statement
9.91
+36.31%
7.27
+11.25%
6.53
+42.92%
4.57
Depreciation And Amortization In Income Statement
9.91
+36.31%
7.27
+11.25%
6.53
+42.92%
4.57
Total Other Finance Cost
-9.70
+10.88%
-10.89
-30.05%
-8.37
-1444.65%
-0.54
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,369.38
+20.57%
1,135.78
+13.59%
999.90
+26.12%
792.81
Current Assets
911.00
+9.13%
834.82
+19.12%
700.80
+26.97%
551.96
Cash Cash Equivalents And Short Term Investments
479.69
-2.33%
491.15
+26.09%
389.51
+11.93%
347.99
Cash And Cash Equivalents
479.69
-2.33%
491.15
+26.09%
389.51
+11.93%
347.99
Receivables
400.90
+26.80%
316.18
+8.74%
290.77
+53.36%
189.60
Accounts Receivable
400.90
+26.80%
316.18
+8.74%
290.77
+53.36%
189.60
Gross Accounts Receivable
416.30
+27.90%
325.48
—
—
Allowance For Doubtful Accounts Receivable
-15.40
-65.59%
-9.30
—
—
Prepaid Assets
—
—
—
—
Other Current Assets
30.41
+10.62%
27.50
+33.96%
20.52
+42.87%
14.37
Total Non Current Assets
458.38
+52.30%
300.96
+0.62%
299.10
+24.18%
240.85
Net PPE
9.30
+53.18%
6.07
-32.08%
8.94
-22.12%
11.47
Gross PPE
16.84
+30.80%
12.88
-12.04%
14.64
-8.52%
16.00
Accumulated Depreciation
-7.54
-10.84%
-6.81
-19.36%
-5.70
-25.93%
-4.53
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
3.09
+0.00%
3.09
+0.00%
3.09
+0.95%
3.06
Other Properties
8.79
+82.15%
4.83
-26.98%
6.61
-18.26%
8.09
Leases
4.96
+0.00%
4.96
+0.43%
4.94
+1.73%
4.86
Goodwill And Other Intangible Assets
425.76
+69.34%
251.42
+2.05%
246.38
+33.67%
184.32
Goodwill
209.84
+48.18%
141.62
+2.07%
138.75
+9.30%
126.94
Other Intangible Assets
215.92
+96.64%
109.81
+2.02%
107.63
+87.55%
57.39
Non Current Deferred Assets
2.27
-91.38%
26.38
-25.05%
35.20
-12.80%
40.37
Non Current Deferred Taxes Assets
2.27
-91.38%
26.38
-25.05%
35.20
-12.80%
40.37
Other Non Current Assets
21.04
+23.17%
17.09
+99.13%
8.58
+83.22%
4.68
Total Liabilities Net Minority Interest
578.43
+27.88%
452.34
+15.24%
392.51
+43.38%
273.76
Current Liabilities
568.52
+26.58%
449.15
+16.07%
386.95
+46.42%
264.27
Payables And Accrued Expenses
63.25
+13.83%
55.57
+7.15%
51.86
+11.14%
46.66
Payables
7.97
-18.27%
9.76
-57.50%
22.95
+4.65%
21.93
Accounts Payable
7.97
-18.27%
9.76
+23.76%
7.88
+17.10%
6.73
Other Payable
—
20.42
+35.48%
15.07
-0.86%
15.20
Current Accrued Expenses
55.28
+20.67%
45.81
+58.50%
28.90
+16.89%
24.73
Pensionand Other Post Retirement Benefit Plans Current
33.55
+26.99%
26.42
+342.32%
5.97
-3.30%
6.18
Current Debt And Capital Lease Obligation
2.20
-13.83%
2.55
-16.10%
3.04
+1.00%
3.01
Current Debt
—
—
—
—
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
2.20
-13.83%
2.55
-16.10%
3.04
+1.00%
3.01
Other Current Liabilities
469.52
+28.77%
364.61
+11.82%
326.08
+56.45%
208.42
Total Non Current Liabilities Net Minority Interest
9.91
+210.82%
3.19
-42.62%
5.56
-41.42%
9.49
Long Term Debt And Capital Lease Obligation
7.33
+141.39%
3.04
-42.11%
5.25
-38.21%
8.49
Long Term Debt
—
—
—
—
Long Term Capital Lease Obligation
7.33
+141.39%
3.04
-42.11%
5.25
-38.21%
8.49
Other Non Current Liabilities
2.58
+1588.89%
0.15
-51.12%
0.31
-68.70%
1.00
Stockholders Equity
737.22
+16.06%
635.18
+13.14%
561.44
+12.49%
499.09
Common Stock Equity
737.22
+16.06%
635.18
+13.14%
561.44
+12.49%
499.09
Capital Stock
1.24
+2.74%
1.20
+1.78%
1.18
+2.96%
1.15
Common Stock
1.24
+2.74%
1.20
+1.78%
1.18
+2.96%
1.15
Share Issued
123.60
+2.74%
120.31
+1.77%
118.22
+3.07%
114.69
Ordinary Shares Number
123.60
+2.74%
120.31
+1.77%
118.22
+3.07%
114.69
Additional Paid In Capital
892.29
+9.72%
813.21
+7.87%
753.87
+5.49%
714.64
Retained Earnings
-156.31
+12.79%
-179.23
+7.43%
-193.61
+10.65%
-216.69
Minority Interest
53.73
+11.32%
48.26
+5.03%
45.95
+130.28%
19.95
Total Equity Gross Minority Interest
790.94
+15.73%
683.45
+12.52%
607.39
+17.02%
519.05
Total Capitalization
737.22
+16.06%
635.18
+13.14%
561.44
+12.49%
499.09
Working Capital
342.48
-11.20%
385.68
+22.88%
313.85
+9.09%
287.69
Invested Capital
737.22
+16.06%
635.18
+13.14%
561.44
+12.49%
499.09
Total Debt
9.53
+70.50%
5.59
-32.56%
8.29
-27.94%
11.50
Capital Lease Obligations
9.53
+70.50%
5.59
-32.56%
8.29
-27.94%
11.50
Net Tangible Assets
311.46
-18.84%
383.76
+21.81%
315.06
+0.09%
314.77
Tangible Book Value
311.46
-18.84%
383.76
+21.81%
315.06
+0.09%
314.77
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
163.40
+49.53%
109.28
+35.28%
80.78
+71.17%
47.20
Cash Flow From Continuing Operating Activities
163.40
+49.53%
109.28
+35.28%
80.78
+71.17%
47.20
Net Income From Continuing Operations
29.73
+74.41%
17.04
-18.95%
21.03
+274.30%
-12.06
Depreciation Amortization Depletion
9.91
+36.31%
7.27
+11.25%
6.53
+42.92%
4.57
Depreciation
0.74
-33.06%
1.10
-5.96%
1.17
-3.77%
1.22
Amortization Cash Flow
9.17
+48.73%
6.16
+15.02%
5.36
+59.92%
3.35
Depreciation And Amortization
9.91
+36.31%
7.27
+11.25%
6.53
+42.92%
4.57
Amortization Of Intangibles
9.17
+48.73%
6.16
+15.02%
5.36
+59.92%
3.35
Other Non Cash Items
—
—
—
0.69
Stock Based Compensation
71.07
+25.38%
56.68
+52.78%
37.10
-44.92%
67.36
Deferred Tax
10.87
+23.30%
8.82
+18.11%
7.46
+206.58%
-7.00
Deferred Income Tax
10.87
+23.30%
8.82
+18.11%
7.46
+206.58%
-7.00
Change In Working Capital
41.83
+114.82%
19.47
+124.84%
8.66
+236.33%
-6.35
Change In Receivables
-36.67
-84.97%
-19.82
+79.54%
-96.88
-34.17%
-72.20
Changes In Account Receivables
-36.67
-84.97%
-19.82
+79.54%
-96.88
-34.17%
-72.20
Change In Prepaid Assets
-1.60
+82.17%
-8.97
-45.64%
-6.16
-8.64%
-5.67
Change In Payables And Accrued Expense
14.82
-25.53%
19.91
+298.58%
4.99
-27.12%
6.85
Change In Other Current Assets
-0.33
+81.06%
-1.72
+28.83%
-2.42
-274.84%
1.38
Change In Other Current Liabilities
65.60
+118.07%
30.08
-72.43%
109.12
+72.43%
63.28
Investing Cash Flow
-181.57
-1415.86%
-11.98
+72.13%
-42.97
-41218.27%
-0.10
Cash Flow From Continuing Investing Activities
-181.57
-1415.86%
-11.98
+72.13%
-42.97
-41218.27%
-0.10
Net PPE Purchase And Sale
—
—
-0.11
-8.65%
-0.10
Purchase Of PPE
—
—
-0.11
-8.65%
-0.10
Capital Expenditure
—
—
-0.11
-8.65%
-0.10
Net Business Purchase And Sale
-180.37
-2492.64%
-6.96
+83.77%
-42.86
0.00
Purchase Of Business
-180.37
-2492.64%
-6.96
+83.77%
-42.86
0.00
Net Other Investing Changes
-1.20
+76.10%
-5.02
-4343.36%
-0.11
-8.65%
-0.10
Financing Cash Flow
6.70
+54.64%
4.33
+16.98%
3.71
+118.83%
-19.68
Cash Flow From Continuing Financing Activities
6.70
+54.64%
4.33
+16.98%
3.71
+118.83%
-19.68
Net Issuance Payments Of Debt
—
0.00
0.00
+100.00%
-33.25
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
—
0.00
0.00
+100.00%
-33.25
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
0.00
0.00
+100.00%
-33.25
Net Long Term Debt Issuance
—
0.00
0.00
+100.00%
-33.25
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
—
—
0.00
0.00
Proceeds From Stock Option Exercised
8.05
+200.15%
2.68
-69.32%
8.74
-35.01%
13.45
Net Other Financing Charges
-1.34
-181.37%
1.65
+132.83%
-5.04
-4128.00%
0.12
Changes In Cash
-11.46
-111.28%
101.64
+144.80%
41.52
+51.45%
27.41
Beginning Cash Position
491.15
+26.09%
389.51
+11.93%
347.99
+8.55%
320.58
End Cash Position
479.69
-2.33%
491.15
+26.09%
389.51
+11.93%
347.99
Free Cash Flow
163.40
+49.53%
109.28
+35.28%
80.78
+71.17%
47.20
Interest Paid Supplemental Data
0.25
-11.93%
0.28
+612.50%
0.04
-94.39%
0.71
Income Tax Paid Supplemental Data
6.64
+76.80%
3.75
+261.06%
1.04
+238.76%
0.31
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category